XueKe Du (Xueke Du)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Urinary Tract Infection

Signaling Pathway

Ejection Fraction

Top Venues

International journal of general medicine

International journal of nanomedicine

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Enhao Huang, Huadao Li, Hanghang Han, Lianshan Guo, Yubing Liang, Zijin Huang, Ke Qin, XueKe Du
Polydopamine-Coated Kaempferol-Loaded MOF Nanoparticles: A Novel Therapeutic Strategy for Postoperative Neurocognitive Disorder. International journal of nanomedicine 19 (2024)
Lini Chen, Weiyong Qin, Jiangdong Wu, Guilin Zhao, Xiaoqing Jiang, Minghui Li, Zijin Huang, XueKe Du
Effect of Remimazolam on Induction and Maintenance of General Anesthesia in Kidney Transplant Patients. International journal of general medicine 17 (2024)
Lini Chen, Weiyong Qin, Jiangdong Wu, Guilin Zhao, Xiaoqing Jiang, Minghui Li, Zijin Huang, XueKe Du
Effect of Remimazolam on Induction and Maintenance of General Anesthesia in Kidney Transplant Patients. International journal of general medicine 17 (2024)
Enhao Huang, Huadao Li, Hanghang Han, Lianshan Guo, Yubing Liang, Zijin Huang, Ke Qin, XueKe Du
Polydopamine-Coated Kaempferol-Loaded MOF Nanoparticles: A Novel Therapeutic Strategy for Postoperative Neurocognitive Disorder. International journal of nanomedicine 19 (2024)
Lini Chen, Yongguo Xie, XueKe Du, Weiyong Qin, Lifu Huang, Junmin Dai, Ke Qin, Jianfeng Huang
The Effect of Different Doses of Ciprofol in Patients with Painless Gastrointestinal Endoscopy. Drug design, development and therapy 17 (2023)
Jinju Li, Rongge Shao, Qiuwen Xie, Ke Qin, ShaoPeng Ming, Yongguo Xie, XueKe Du
Ulinastatin promotes macrophage efferocytosis and ameliorates lung inflammation via the ERK5/Mer signaling pathway. FEBS open bio 12 (8) (2022)